News
-
-
-
PRESS RELEASE
Communiqué de presse : ASCO : Sarclisa, en association avec un protocole VRd, est le premier anti-CD38 permettant d’améliorer significativement la survie sans progression des patients […]
Sarclisa associé à VRd améliore la survie sans progression chez les patients atteints de myélome multiple non éligibles à une transplantation, selon l'étude IMROZ publiée dans NEJM -
PRESS RELEASE
Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3
Sarclisa in combo with VRd significantly enhances progression-free survival in newly diagnosed transplant-ineligible multiple myeloma in phase 3 study at ASCO. Full data published in NEJM -
-
-
PRESS RELEASE
Ilmor and GM Marine Host Displays in Lake Havasu
Ilmor and GM Marine successfully showcased marinized engines at SuperCat Fest West and Desert Storm LHC in Lake Havasu City, AZ. New products include the Supercharged 650 engine and MV8 570, setting new standards in power and reliability -
-
-
